According to Endo International
's latest financial reports the company has $0.77 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.77 B | -23.65% |
2022-12-31 | $1.01 B | -32.4% |
2021-12-31 | $1.50 B | 24.21% |
2020-12-31 | $1.21 B | -16.58% |
2019-12-31 | $1.45 B | 26.58% |
2018-12-31 | $1.14 B | 16.47% |
2017-12-31 | $0.98 B | 90.74% |
2016-12-31 | $0.51 B | 89.9% |
2015-12-31 | $0.27 B | -33% |
2014-12-31 | $0.40 B | -22.8% |
2013-12-31 | $0.52 B | -0.58% |
2012-12-31 | $0.52 B | -3.27% |
2011-12-31 | $0.54 B | 17.46% |
2010-12-31 | $0.46 B | -36.46% |
2009-12-31 | $0.73 B | -6.19% |
2008-12-31 | $0.78 B | 17.85% |
2007-12-31 | $0.66 B | 5.67% |
2006-12-31 | $0.62 B | 25.38% |
2005-12-31 | $0.50 B | 80.18% |
2004-12-31 | $0.27 B | 21.11% |
2003-12-31 | $0.22 B | 303.45% |
2002-12-31 | $56.9 M | -40.33% |
2001-12-31 | $95.35 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Zogenix ZGNX | N/A | N/A | ๐บ๐ธ USA |
Cara Therapeutics
CARA | $0.10 B | -87.05% | ๐บ๐ธ USA |